Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Challenge & Pitfalls
Sara E. Monaco, MD
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an important procedure for evaluating mediastinal masses and lymphadenopathy given its minimally invasive nature and ability to spare patients from having more invasive procedures (e.g. EBUS-TBNA for lung cancer staging in lieu of mediastinoscopy). The on-site evaluation of these FNAs is essential in order to answer an important question (ex. neoplastic vs. non-neoplastic) and to decide if a more invasive procedure is required. Due to the importance of the clinical decisions and the need to have rapid answers based on limited material, it is essential for pathologists to understand how far they can go in their immediate assessment and how the diagnosis rendered will impact the surgical decision making. This presentation will emphasize the diagnostic challenges and pitfalls in a case-based approach.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
Understand the diagnostic value and advantages of EBUS-TBNA.
Employ a practical cytological approach to making a diagnosis in EBUS-TBNAs
Recognize the pitfalls and diagnostic challenges in EBUS-TBNAs
Understand the utility of ancillary studies that can be utilized in EBUS-TBNAs.
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Sara E. Monaco, MD
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant